Cresagen 5 mg, 10 mg, 20 mg, 40 mg FC tablets,
PDF Leaflet Revision Date: 28 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For hypercholesterolaemia and dyslipidaemia management.
Dosage (summary)
Start at 5 mg once daily; adjust based on response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Asian ancestry
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Ciclosporin
- Gemfibrozil
- Fusidic acid
- Protease inhibitors
Contraindications
- Hypersensitivity to rosuvastatin
- Active liver disease
- Severe renal impairment
- Pregnancy and lactation
- Myopathy
Common side effects
- Myalgia
- Headache
- Dizziness
- Constipation
- Nausea
Counselling Points
- Report muscle pain or weakness immediately.
- Monitor liver function regularly.
- Use contraception if of childbearing potential.
- Avoid alcohol consumption.
Serious warnings
- Risk of myopathy and rhabdomyolysis
- Liver enzyme elevation
- Diabetes risk
- Cognitive impairment
Important Disclaimer
The Cresagen 5 mg, 10 mg, 20 mg, 40 mg FC tablets, professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
